JP2019509318A5 - - Google Patents

Download PDF

Info

Publication number
JP2019509318A5
JP2019509318A5 JP2018549896A JP2018549896A JP2019509318A5 JP 2019509318 A5 JP2019509318 A5 JP 2019509318A5 JP 2018549896 A JP2018549896 A JP 2018549896A JP 2018549896 A JP2018549896 A JP 2018549896A JP 2019509318 A5 JP2019509318 A5 JP 2019509318A5
Authority
JP
Japan
Prior art keywords
composition according
days
compound
administered
clostridium difficile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018549896A
Other languages
English (en)
Japanese (ja)
Other versions
JP7458706B2 (ja
JP2019509318A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/023958 external-priority patent/WO2017165729A1/en
Publication of JP2019509318A publication Critical patent/JP2019509318A/ja
Priority to JP2022076605A priority Critical patent/JP2022115985A/ja
Priority to JP2023183167A priority patent/JP2024023187A/ja
Publication of JP2019509318A5 publication Critical patent/JP2019509318A5/ja
Application granted granted Critical
Publication of JP7458706B2 publication Critical patent/JP7458706B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018549896A 2016-03-24 2017-03-24 クロストリジウム・ディフィシル感染を処置及び予防するための方法 Active JP7458706B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022076605A JP2022115985A (ja) 2016-03-24 2022-05-06 クロストリジウム・ディフィシル感染を処置及び予防するための方法
JP2023183167A JP2024023187A (ja) 2016-03-24 2023-10-25 クロストリジウム・ディフィシル感染を処置及び予防するための方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662312996P 2016-03-24 2016-03-24
US62/312,996 2016-03-24
US201662320053P 2016-04-08 2016-04-08
US62/320,053 2016-04-08
PCT/US2017/023958 WO2017165729A1 (en) 2016-03-24 2017-03-24 Methods for treating and preventing c. difficile infection

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022076605A Division JP2022115985A (ja) 2016-03-24 2022-05-06 クロストリジウム・ディフィシル感染を処置及び予防するための方法

Publications (3)

Publication Number Publication Date
JP2019509318A JP2019509318A (ja) 2019-04-04
JP2019509318A5 true JP2019509318A5 (enExample) 2024-01-09
JP7458706B2 JP7458706B2 (ja) 2024-04-01

Family

ID=59900751

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018549896A Active JP7458706B2 (ja) 2016-03-24 2017-03-24 クロストリジウム・ディフィシル感染を処置及び予防するための方法
JP2022076605A Pending JP2022115985A (ja) 2016-03-24 2022-05-06 クロストリジウム・ディフィシル感染を処置及び予防するための方法
JP2023183167A Pending JP2024023187A (ja) 2016-03-24 2023-10-25 クロストリジウム・ディフィシル感染を処置及び予防するための方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022076605A Pending JP2022115985A (ja) 2016-03-24 2022-05-06 クロストリジウム・ディフィシル感染を処置及び予防するための方法
JP2023183167A Pending JP2024023187A (ja) 2016-03-24 2023-10-25 クロストリジウム・ディフィシル感染を処置及び予防するための方法

Country Status (13)

Country Link
US (3) US20170319603A1 (enExample)
EP (1) EP3432891A4 (enExample)
JP (3) JP7458706B2 (enExample)
CN (2) CN119454720A (enExample)
AU (3) AU2017238644B2 (enExample)
BR (2) BR112018069303A2 (enExample)
CA (1) CA3018872A1 (enExample)
MX (2) MX2018011413A (enExample)
MY (1) MY197627A (enExample)
PH (1) PH12018502020A1 (enExample)
RU (1) RU2751509C1 (enExample)
SG (2) SG10201913559VA (enExample)
WO (1) WO2017165729A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018011413A (es) * 2016-03-24 2019-01-10 Paratek Pharm Innc Metodos para tratar y prevenir infeccion por c. difficile.
TW202206081A (zh) * 2016-08-03 2022-02-16 美商派瑞泰Ｓｐｖ２有限公司 ９—胺甲基米諾四環素化合物及其用途
SG10201913599RA (en) * 2016-11-01 2020-02-27 Paratek Pharm Innc 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (cabp)
JP7110562B2 (ja) * 2017-09-06 2022-08-02 株式会社三洋物産 遊技機
JP7110560B2 (ja) * 2017-09-06 2022-08-02 株式会社三洋物産 遊技機
JP7110563B2 (ja) * 2017-09-06 2022-08-02 株式会社三洋物産 遊技機
JP2019136431A (ja) * 2018-02-15 2019-08-22 株式会社三洋物産 遊技機
JP2019136430A (ja) * 2018-02-15 2019-08-22 株式会社三洋物産 遊技機
JP2019136429A (ja) * 2018-02-15 2019-08-22 株式会社三洋物産 遊技機
MX2021002503A (es) * 2018-09-04 2021-06-15 Paratek Pharm Innc Métodos de tratamiento de infecciones micobacterianas usando compuestos de tetraciclina.
JP7369709B2 (ja) * 2018-10-10 2023-10-26 ニュートリー株式会社 クロストリジウム・ディフィシル菌感染症の予防及び／又は治療剤
CN115667210A (zh) * 2020-06-11 2023-01-31 帕拉特克药品公司 奥马环素的晶形、其合成方法及其使用方法
PT117254B (pt) 2021-05-26 2024-04-18 Hovione Farm S A Método de síntese de compostos 9-aminometil tetraciclinas
JP2023105293A (ja) * 2022-07-21 2023-07-28 株式会社三洋物産 遊技機
JP2023105292A (ja) * 2022-07-21 2023-07-28 株式会社三洋物産 遊技機

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9206300A (pt) * 1991-07-24 1994-08-02 Procter & Gamble Processos e composições de tratamento antimicrobiano
SI1301467T1 (sl) * 2000-07-07 2007-02-28 Tufts College 9-substituirane minociklinske spojine
US7553828B2 (en) * 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
JP2004537544A (ja) * 2001-07-13 2004-12-16 パラテック ファーマシューティカルズ インコーポレイテッド 標的治療活性を有するテトラサイクリン化合物
BRPI0620430A2 (pt) * 2005-12-22 2011-11-08 Wyeth Corp métodos para tratar infecções do trato gastrointestinal com tigeciclina
US9078811B2 (en) * 2006-01-24 2015-07-14 Paratek Pharmaceuticals, Inc. Methods of increasing oral bioavailability of tetracyclines
TWI680117B (zh) * 2008-05-19 2019-12-21 派洛泰克藥物股份有限公司 四環素化合物之甲苯磺酸鹽及同素異形體
US20110294726A1 (en) * 2009-02-11 2011-12-01 Cedars-Sinai Medical Center Antibiotic therapy to reduce the likelihood of developing post-infectious irritable bowel syndrome
BR112012026021B1 (pt) * 2010-04-15 2022-05-03 Progenics Pharmaceuticals, Inc Anticorpos, seus fragmentos de ligação ao antígeno e seus usos, composições e uso das mesmas, linhagem de células de hibridoma, kit, ácido nucleico, e vetor de expressão
WO2012050826A1 (en) * 2010-09-29 2012-04-19 St. Jude Children's Research Hostpital Methods for treating clostridium difficile infections
WO2012065028A2 (en) * 2010-11-11 2012-05-18 Concert Pharmaceuticals Inc. Substituted tetracyclines
US11185562B2 (en) * 2013-02-04 2021-11-30 Seres Therapeutics, Inc. Compositions and methods for inhibition of pathogenic bacterial growth
US20140274800A1 (en) * 2013-03-13 2014-09-18 Procarta Biosystems Ltd. Transcription factor decoys for the treatment and prevention of infections caused by bacteria including clostridium difficile
MX2018011413A (es) * 2016-03-24 2019-01-10 Paratek Pharm Innc Metodos para tratar y prevenir infeccion por c. difficile.

Similar Documents

Publication Publication Date Title
CN109311832A (zh) 沃替西汀的帕莫酸盐及其晶型
JP2014528901A5 (enExample)
RU2010140682A (ru) Способ лечения пациента от инфекции, фармацевтическая композиция (варианты) и лекарственное средство
JP2009544585A5 (enExample)
BRPI0512893A (pt) métodos de determinação da eficácia da terapia no tratamento da amiloidose e de identificação de paciente como prodrÈmico para doença associada com a deposição amilóide e respectivos compostos
RU2018103081A (ru) Способы лечения колитов
RU2017134443A (ru) Способ лечения с применением традипитанта
JP2020526553A5 (enExample)
JP2017533972A5 (enExample)
RU2016127558A (ru) Стероидное соединение для применения в лечении печеночной энцефалопатии
JP2016509050A5 (enExample)
EA201791138A1 (ru) Фармацевтическая композиция, ее приготовление и применения
EP4578461A3 (en) Methods of treating parkinsons disease by administration of apomorphine to an oral mucosa
MX2019001412A (es) Compuestos de 9-aminometil minociclina y usos de los mismos.
JP2023553253A5 (enExample)
JP2018536638A5 (enExample)
JP2017508737A5 (enExample)
EP4389218A3 (en) Composition for treating joint disease and kit containing same
RU2018130097A (ru) Лечение экземы кистей
JP2019535830A5 (enExample)
FI3359572T3 (fi) Menetelmä multippeliskleroosin hoitamiseksi
LU82013A1 (fr) Nouvelles poudres lyophilisees contenant un sel de l'acide thiazolidine-4-carboxylique et leur procede de preparation
RU2018114457A (ru) Лечение syd985 пациентов с t-dm1 рефрактерным раком
JP2023531930A5 (enExample)
JP2014509656A5 (enExample)